294 results
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Medications - Summary Table ... Aspirin - Inhibits ... in a-fib P2Y12 Inhibitors ... ticagrelor) - Inhibits ... Medications #Summary #Table
Cholinesterase Inhibitor (ChEl) and Memantine Deprescribing Algorithm 

To support health care professionals in employing the recommendations
Cholinesterase Inhibitor ... Deprescribing Algorithm ... This algorithm helps ... cholinesterase inhibitors ... Cholinesterase #Inhibitors
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
PDE5 inhibitors ... PDE5 inhibitors  ... PDE5 inhibitors ... #medications #dosing ... #drugs #table #
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
Xa Inhibitors - ... Rivaroxaban Oral Xa inhibitors ... overview of the dosing ... /ambcarerx #XaInhibitors ... #Rivaroxaban #Dosing
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Platelet Aggregation Inhibitors ... #AntiPlatelet #Inhibitors ... #Pharmacology #Table
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
, Varenicline (tablet ... release (SR) (tablet ... Therapy #Comparison #Table ... #Agents #Dosing
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
approved SGLT2 inhibitors ... Ertugliflozin #SGLT2 #Inhibitors ... #pharmacology #table
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Summary table of ... Selective factor Xa inhibitors ... thrombin (factor lla) inhibitors ... doac #comparison #table
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... #medications #table
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Pharmacology #Dosing ... #Dosing #Renal ... Impairment #CKD #Table